Molecular Markers of Ischemic Stroke
The purpose of the study was to evaluate the clinical significance of CNS biological markers in an ischemic stroke.Materials and methods. Blood serum biomarkers of CNS were assayed by ELISA in patients suffering from cerebrovascular disorders of ischemic origin. Neuron-specific enolase, brain-derive...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2019-11-01
|
Series: | Общая реаниматология |
Subjects: | |
Online Access: | https://www.reanimatology.com/rmt/article/view/1814 |
_version_ | 1826562170786152448 |
---|---|
author | A. M. Golubev M. V. Petrova A. V. Grechko V. E. Zakharchenko A. N. Kuzovlev A. V. Ershov |
author_facet | A. M. Golubev M. V. Petrova A. V. Grechko V. E. Zakharchenko A. N. Kuzovlev A. V. Ershov |
author_sort | A. M. Golubev |
collection | DOAJ |
description | The purpose of the study was to evaluate the clinical significance of CNS biological markers in an ischemic stroke.Materials and methods. Blood serum biomarkers of CNS were assayed by ELISA in patients suffering from cerebrovascular disorders of ischemic origin. Neuron-specific enolase, brain-derived neutrophic factor (BDNF), glial-derived neutrophic factor (GDNF), protein S-100 total (ɑβ–ββ), sialyl carbohydrate antigen (KL-6), vascular endothelial growth factor, and superoxide dismutase were analyzed. All tests were carried out using automatic microplate immunoassay analyzer Immunomat TM. The study included 43 patients of 50 to 80 years of age, suffering from cerebrovascular disorders; among them there were 24 women and 19 men. Blood serum biomarkers of CNS were assayed within the first 3–6 hours, and on week 2, 3, and 4 from onset of the disease. The control group consisted of 20 volunteers (apparently healthy donors). Statistical analysis was carried out using non-parametrical Mann–Whitney test. Results were considered as significant at P 0.05.Results. During the pre-necrotic and early necrotic period, higher neuron-specific enolase, protein S-100, superoxide dismutase, and lower brain-derived neutrophic factor and glial-derived neutrophic factor were observed, reflecting structural brain alterations due to disturbed circulation. At later follow-up time-points, BDNF, GDNF, VEGF, and KL-6 increased evidencing activated CNS regeneration processes.Conclusion. The content of biological markers in blood serum of ischemic stroke patients reflects the disease stages, which helps managing the CNS regeneration processes. |
first_indexed | 2024-04-10T01:27:09Z |
format | Article |
id | doaj.art-6959fca1098f4c32894215838a37fa1c |
institution | Directory Open Access Journal |
issn | 1813-9779 2411-7110 |
language | English |
last_indexed | 2025-03-14T09:43:49Z |
publishDate | 2019-11-01 |
publisher | Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia |
record_format | Article |
series | Общая реаниматология |
spelling | doaj.art-6959fca1098f4c32894215838a37fa1c2025-03-02T11:29:37ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102019-11-01155112210.15360/1813-9779-2019-5-11-221704Molecular Markers of Ischemic StrokeA. M. Golubev0M. V. Petrova1A. V. Grechko2V. E. Zakharchenko3A. N. Kuzovlev4A. V. Ershov5V. A. Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Peoples’ Friendship University of RussiaPeoples’ Friendship University of Russia, Federal Research and Clinical Center of Intensive Care Medicine and RehabilitologyFederal Research and Clinical Center of Intensive Care Medicine and RehabilitologyFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology,V. A. Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, A. I. Evdokimov Moscow State University of medicine and dentistry, Ministry of Health of RussiaV. A. Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, I. M. Sechenov First Moscow State Medical University, Ministry of Health of RussiaThe purpose of the study was to evaluate the clinical significance of CNS biological markers in an ischemic stroke.Materials and methods. Blood serum biomarkers of CNS were assayed by ELISA in patients suffering from cerebrovascular disorders of ischemic origin. Neuron-specific enolase, brain-derived neutrophic factor (BDNF), glial-derived neutrophic factor (GDNF), protein S-100 total (ɑβ–ββ), sialyl carbohydrate antigen (KL-6), vascular endothelial growth factor, and superoxide dismutase were analyzed. All tests were carried out using automatic microplate immunoassay analyzer Immunomat TM. The study included 43 patients of 50 to 80 years of age, suffering from cerebrovascular disorders; among them there were 24 women and 19 men. Blood serum biomarkers of CNS were assayed within the first 3–6 hours, and on week 2, 3, and 4 from onset of the disease. The control group consisted of 20 volunteers (apparently healthy donors). Statistical analysis was carried out using non-parametrical Mann–Whitney test. Results were considered as significant at P 0.05.Results. During the pre-necrotic and early necrotic period, higher neuron-specific enolase, protein S-100, superoxide dismutase, and lower brain-derived neutrophic factor and glial-derived neutrophic factor were observed, reflecting structural brain alterations due to disturbed circulation. At later follow-up time-points, BDNF, GDNF, VEGF, and KL-6 increased evidencing activated CNS regeneration processes.Conclusion. The content of biological markers in blood serum of ischemic stroke patients reflects the disease stages, which helps managing the CNS regeneration processes.https://www.reanimatology.com/rmt/article/view/1814ischemic strokemolecular markers |
spellingShingle | A. M. Golubev M. V. Petrova A. V. Grechko V. E. Zakharchenko A. N. Kuzovlev A. V. Ershov Molecular Markers of Ischemic Stroke Общая реаниматология ischemic stroke molecular markers |
title | Molecular Markers of Ischemic Stroke |
title_full | Molecular Markers of Ischemic Stroke |
title_fullStr | Molecular Markers of Ischemic Stroke |
title_full_unstemmed | Molecular Markers of Ischemic Stroke |
title_short | Molecular Markers of Ischemic Stroke |
title_sort | molecular markers of ischemic stroke |
topic | ischemic stroke molecular markers |
url | https://www.reanimatology.com/rmt/article/view/1814 |
work_keys_str_mv | AT amgolubev molecularmarkersofischemicstroke AT mvpetrova molecularmarkersofischemicstroke AT avgrechko molecularmarkersofischemicstroke AT vezakharchenko molecularmarkersofischemicstroke AT ankuzovlev molecularmarkersofischemicstroke AT avershov molecularmarkersofischemicstroke |